{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:42:56Z","timestamp":1770680576750,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical University of Lodz, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.regpep.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T16:07:34Z","timestamp":1376669254000},"page":"104-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus"],"prefix":"10.1016","volume":"186","author":[{"given":"M.","family":"Kosinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Vedtofte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Grycewiczv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Swierzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Cypryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2013.08.002_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2013.08.002_bb0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9378(96)70456-8","article-title":"Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes","volume":"174","author":"Damm","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.regpep.2013.08.002_bb0015","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1210\/jc.2010-0119","article-title":"Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects","volume":"95","author":"Hansen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0020","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2337\/db09-1414","article-title":"The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action","volume":"59","author":"Hare","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2013.08.002_bb0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1463-1326.2011.01549.x","article-title":"Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity","volume":"14","author":"Knop","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09513590601137004","article-title":"Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus","volume":"23","author":"Cypryk","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.regpep.2013.08.002_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/dom.12082","article-title":"Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus","volume":"15","author":"Bonde","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-013-2841-0","article-title":"Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies","volume":"56","author":"Calanna","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2013.08.002_bb0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/db07-0100","article-title":"Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?","volume":"56","author":"Knop","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2013.08.002_bb0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/jc.2011-2594","article-title":"Impaired incretin-induced amplification of insulin secretion following glucose homeostatic dysregulation in healthy subjects","volume":"97","author":"Hansen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2337\/db09-1899","article-title":"Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?","volume":"59","author":"Meier","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2013.08.002_bb0060","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1210\/jc.2003-030738","article-title":"The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","article-title":"The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects","volume":"52","author":"Kjems","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2013.08.002_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsb\u00f8ll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2013.08.002_bb0075","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1210\/jc.2011-2594","article-title":"Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects","volume":"97","author":"Hansen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2013.08.002_bb0080","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.08.115","article-title":"Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat","volume":"362","author":"Piteau","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2013.08.002_bb0085","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/hmg\/ddp178","article-title":"Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired \u03b2-cell function","volume":"18","author":"Shu","year":"2009","journal-title":"Hum Mol Genet"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T06:33:38Z","timestamp":1563690818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011513001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":17,"alternative-id":["S0167011513001225"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2013.08.002","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Regulatory Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regpep.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}